Clinical trial · Interventional
Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm
Preoperative, Specialty Palliative Care for Patients Considering Pancreatic Surgery: Pilot Feasibility and Acceptability Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Study closed before opening to accrual; Insufficient staff
Summary
Brief summary (as posted)
This clinical trial evaluates a palliative care consultation for improving communication between providers and patients considering surgery for a pancreatic neoplasm. Pancreatic operations have known complications that can affect quality of life. Palliative care has been shown to improve patient reported quality of life and functional outcomes. Receiving a palliative care consultation may improve communication and decision making for patients considering surgery for a pancreatic neoplasm.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Neoplasm | Pancreatic Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Best Practice | Other | — | UNRESOLVED |
| Palliative Care Consultation | Procedure | — | UNRESOLVED |
| Survey Administration | Other | — | UNRESOLVED |
| Tumor Board Review | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Arm I (Usual care)
- description
- Patients receive usual care and undergo evaluation by a tumor board within 14 days of baseline.
- interventionNames
- Other: Best Practice
- Other: Survey Administration
- Other: Tumor Board Review
- type
- EXPERIMENTAL
- label
- Arm II (Palliative care visit)
- description
- Patients attend a palliative care visit over 60 minutes to discuss their illness, quality of life, fears and concerns and communication preferences within 7 days of baseline. Patients also undergo evaluation by a tumor board within 14 days of baseline.
- interventionNames
- Procedure: Palliative Care Consultation
- Other: Survey Administration
- Other: Tumor Board Review
Primary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults (18 years or older) * Pancreatic neoplasm pathology * Ability to read, write, and speak in English * Has decisional capacity * Expected to be seen and discussed at PCSC and seeing a surgeon as part of their tumor board evaluation Exclusion Criteria: * Metastatic pancreatic neoplasm * Currently incarcerated * Currently is or previously has received palliative care, or are unwilling to forego palliative care for the first 90 days post randomization * Evidence of any behavior, condition, or circumstance (including, but not limited to: blindness, deafness, serious behavior or mental health conditions, discontinuing curative treatment, lack of access to technology, etc) that would interfere with their ability to complete study procedures as noted within the chart
References
Publications (0)
Data not yet available